Background/Aims: Chronic intermittent hypobaric hypoxia (CIHH) protects the heart against ischemia/reperfusion (I/R) injury. This study investigated the calcium homeostasis mechanism and the role of Na + /Ca 2+ exchanger (NCX) in the cardiac protective effect of CIHH in developing rats. Methods: Neonatal male rats received CIHH treatment or no treatment (control) in a hypobaric chamber simulating 3000-meter altitude for 42 days. The left ventricular function of isolated hearts was evaluated after 30 minutes of ischemia and 60 minutes of reperfusion. Myocardial infarct size, intracellular Ca 2+ concentration ([Ca 2+ ] i ), Na + -Ca 2+ exchanger currents (I Na/Ca ) in ventricular myocytes, and NCX1 protein level in the sarcolemmal membrane were determined. Results: The recovery of cardiac function after I/R was improved, with the myocardial infarct size reduced, in CIHH rats compared with control rats (p<0.05). These effects were attenuated by Bay K8644, an L-type Ca 2+ channel agonist, or ryanodine, a sarcoplasmic reticulum Ca 2+ channel receptor activator. Furthermore, the increases in [Ca 2+ ] i during I/R were blunted in CIHH rats, but this effect was abolished by Bay K8644 or chelerythrine, a protein kinase C (PKC) inhibitor. The I Na/Ca was decreased and the reversal potential of I Na/Ca was shifted toward negative potential during simulated ischemia in the control cardiomyocytes (p<0.05). The inhibition of NCX1 protein expression during I/R was smaller in the CIHH rats than in the control rats (p<0.05). Conclusion: These data suggest that CIHH protects developing rat hearts during I/R by enhancing the resistance against calcium overload and by preserving normal I Na/Ca and NCX1 protein. PKC activation might be involved in this protective process of CIHH.
Introduction
Ischemic heart disease is a leading cause of death in hospitalized patients. During myocardial ischemia/reperfusion (I/R), intracellular calcium concentration ([Ca 2+ ] i ) overload is a prime cause of the cellular injury and myocardial apoptosis [1] . An excessive increase of [Ca 2+ ] i causes mitochondrial dysfunction, reduces adenosine triphosphate (ATP) production [2] , and activates Ca 2+ -dependent protease [3] , all of which contribute to impairment of the intracellular organelles, such as cytoplasmic and mitochondrial membranes. In addition, an increase in [Ca 2+ ] i decreases the Ca 2+ -sensitivity of the myofilaments and subsequently causes depressed myocardial contractility [4] . Disturbance of Ca 2+ entry and extrusion during I/R may result in [Ca 2+ ] i overload. Most trans-sarcolemmal Ca 2+ extrusions are mediated by the Na + -Ca 2+ exchanger (NCX) in forward mode [5, 6] , and the sarcolemmal Ca 2+ pump contributes less than 3% of the total extrusion of cytosolic Ca 2+ in cardiac myocytes under physiological conditions. However, the Na + -Ca 2+ exchange acts in reverse mode during I/R, allowing Ca 2+ entry into the cell. Previous studies have shown that Ca 2+ entry into cardiac myocytes during I/R is predominantly through the NCX in reverse mode [6, 7] .
It has been recognized for decades that long-term high-altitude hypoxia adaptation increases cardiac tolerance to ischemia/hypoxia [8] . Moderate chronic intermittent hypobaric hypoxia (CIHH), similar to ischemic preconditioning and long-term adaptation to high-altitude hypoxia, protects the heart against I/R injury [9] [10] [11] [12] . This CIHH-induced cardiac protection persists longer than ischemic preconditioning [13, 14] and is associated with less side effects on the body, such as polycythemia, right ventricular hypertrophy and pulmonary hypertension compared with long-term adaptation to high-altitude hypoxia [15] [16] [17] . In addition, CIHH increases the electrical stability of the cell membrane, preserves the contractility of the myocardium, and prevents apoptosis of cardiomyocytes [18] [19] [20] [21] .
Multiple mechanisms and pathways may be involved in the cardio-protective effect of CIHH, such as induction of heat shock protein 70 expression, promotion of myocardial capillary proliferation, activation of an ATP-sensitive potassium channel, inhibition of mitochondrial permeability transition pore opening, and activation of protein kinase C (PKC) [18] [19] [20] [21] [22] [23] [24] [25] . It has also been reported that CIHH may contribute to maintaining Ca 2+ homeostasis and contraction by regulating the activity of ryanodine receptors (RyRs), sarcoplasmic reticulum Ca 2+ -ATPase protein, and NCX during I/R in adult rats [26] . It is well known that developing, or young, animals are different from adult animals in morphology, function, and metabolism and that some regular changes occur during development. Since age is an important factor in the tolerance of the heart to ischemia, an animal's age significanly affects the cardiac protective effect induced by hypoxia adaptation [27, 28] . For calcium homeostasis, the basal myocardium [Ca 2+ ] i in developing animals is low and increases along with the cardiac maturation [29] . Cardiac sarcoplasmic reticulum is less developed, while NCX is highly expressed in juvenile animals compared with adult animals [29] . During ontogenetic development, the tolerance of the heart to I/R and acclimatization to high-altitude hypoxia changes significantly [29, 30] .
Although abundant data are available concerning the effects of CIHH on the adult myocardium, little is known about the influence of CIHH on cardiac function in developing animals. Our previous study [31] showed that CIHH simulating 5000-meter altitude for 28 days, 6 hours per day induces cardioprotection in adult rats but has harmful effects in developing rats. However, mild CIHH, which simulates 3000-meter altitude for 28 days, 5 hours per day, produces cardiac protection in developing rats [31] . Therefore, we hypothesized that different mechanisms account for CIHH cardiac protection in adult and developing rats and that alteration of NCX activity is responsible for the cardiac protection of CIHH in developing rats. The objective of this study was to identify the mechanism of the cardioprotective effect of CIHH against I/R injury and to determine the role of NCX in maintaining calcium homeostasis by CIHH in developing rats.
Materials and Methods

Drugs
Collagenase II was purchased from Invitrogen Gibco (Grand Island, NY, USA). Fluo3-AM was purchased from Dojindo Molecular Technologies, Inc. (Tokyo, Japan). A bicinchoninic acid protein assay kit was purchased from Pierce Biotechnology, Inc. (Rockford, IL, USA). Bay K8644, ryanodine, chelerythrine, tetraethylammonium, Mg-ATP, K 2 -ATP, Na 2 -creatine phosphate, nifedipine, taurine, glibenclamide, and ouabain etc. were all purchased from Sigma-Aldrich Co (St Louis, MO, USA).
CIHH procedure
All animal experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals (Publication 85-23, revised 1996; National Institutes of Health, Bethesda, MD), and all techniques and procedures were reviewed and approved by Hebei Medical University Institutional Animal Care&Use Committee. Age-and body-weight-matched postnatal male Sprague-Dawley (SD) rats were obtained from the Experimental Animal Center of Hebei Medical University and were divided into two groups: CIHH group, and control group (CON). Immediately after birth, the CIHH rats and their mothers were put into to a hypobaric chamber mimicking 3000-meter altitude (P B = 525 mmHg, P O2 = 108.8 mmHg, 5 hours per day) for 42 days. The control rats and their mothers were housed in the same environment as the CIHH rats but without CIHH exposure. Both CIHH and CON rats were housed at room temperature with a natural light/ dark (12 hours/12 hours) cycle.
Measurement of ventricular function in isolated rat hearts
The rats were anesthetized with sodium pentobarbital (50 mg/kg) and their hearts were quickly removed and placed in ice-cold Krebs-Henseleit buffer containing (in mmol/L): NaCl 118.0, KCl 4.7, CaCl 2 2.5, MgSO 4 1.2, NaHCO 3 25.0, KH 2 PO 4 1.2, and glucose 11.0 (gassed with 95% O 2 and 5% CO 2 , pH adjusted to 7.4). Then the hearts were retrogradely perfused via the aorta with Krebs-Henseleit buffer at constant pressure (10 kPa) and temperature (37°C) on a Langendorff apparatus (Chengdu Instrument, Sichuan, China). A water-filled latex balloon-tipped catheter was placed into the left ventricle through the left atrium and left ventricular end diastolic pressure (LVEDP) was adjusted to 3-10 mmHg. The distal end of the catheter was connected to a pressure transducer (Gould P23Db, AD Instrument Ltd., Australia). Left ventricular developing pressure (LVDP), LVEDP, maximum rate of rise of left ventricular developed pressure (+(LVdP/dt) max ), maximum rate of decline of left ventricular developed pressure (-(LVdP/dt) max ), and coronary flow (CF) were continuously recorded. The Chart software (AD Instrument Ltd., Australia) was used for data collection and processing. After 20 minutes of stabilization with Krebs-Henseleit buffer, the heart was subjected to 30 minutes of global no-flow ischemia followed by 60 minutes of reperfusion. For myocardial infarction determination, the reperfusion time for the heart was prolonged to 120 minutes. In these experiments, we administered Bay K8644 or ryanodine at the beginning of reperfusion.
Determination of myocardial infarct size
At the end of reperfusion, the heart was removed quickly and then cut into 1.5-mm-thick slices; the slices were perpendicular to the septum from the apex to the base. Then the slices were incubated in sodium phosphate buffer containing 1% (wt/vol) 2,3,5-triphenyl-tetrazolium chloride at 37°C for 10 minutes to visualize the unstained infarct region. Pictures were taken with a digital camera, and analyzed with an image processing system (Motic Med 6.0, Xiamen, China). The extent of infarct of the myocardium was expressed as the percentage of the infarct size to the ventricular size.
Preparation of single ventricular myocytes
Single ventricular myocytes were isolated by enzymatic dissociation as described previously [32] . Briefly, the control and CIHH rats were anaesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg) and heparin (300 U/kg). The rat heart was excised and retrogradely perfused via the aorta for 5 minutes on a Langendorff apparatus (Chengdu Instrument, Sichuan, China) with oxygenated Ca . Single myocytes were harvested after filtration through a nylon mesh and stored in a KB solution at room temperature for at least 1 hour; then the concentration of Ca 2+ in the KB solution was gradually increased to 1 mmol/L before the experiment. ] i recording was performed at room temperature (25 °C). Fluorescence intensity was recorded and images were scanned during each experiment according to the response of the cells, and the data were collected and stored in a computer.
Measurement of [Ca
Measurement of NCX currents
Whole-cell patch-clamp recordings were performed in isolated ventricular myocytes. The myocytes were placed in the recording chamber mounted on the stage of an inverted IX71 microscope (Olympus, Center Valley, PA). After the cells settled to the bottom of the chamber, they were superfused with extracellular solution containing (in mmol/L): NaCl 140, CaCl 2 2.0, MgCl 2 2.0, HEPES 5.0, glucose 10, Oubain 0.02, BaCl 2 .1.0, CsCl 2 2.0, nifedipine 0.001 (gassed with 100% O 2, pH adjusted to 7.4 with NaOH) for 10 minutes at a rate of 2-3 mL/minute at room temperature (25 °C). Transmembrane currents were recorded with a 200 B Axopatch amplifier (Axon Instruments, Inc., Foster City, CA, USA). Glass microelectrodes were made via two-stage pulling using a P-97 microelectrode puller (Sutter Instrument Co., Novato, CA, USA) and After the giga Ω seal was formed, the membrane was ruptured with gentle suction to obtain wholecell configuration. Membrane capacitance and series resistance were then compensated to minimize the duration of the capacitive current. Computer-programmed voltage pulses were applied to the recorded cell. For Ni 2+ -sensitive I Na/Ca recording, K + in the external solution was replaced by Cs + (to abolish inward rectifier K + current), and 10 μmol/L nifedipine and 20 μmol/L ouabain (to inhibit L-type Ca 2+ currents and Na + pump currents, respectively) were added. Glibenclamide (2 μmol/L) and hexamethyleneamil oride (2 μmol/L) were also added to the ischemic solution to block the ATP-sensitive K + channel and Na + /H + exchange, respectively. I Na/Ca was elicited using a ramp voltage from -40 mV to +80 mV and then to -120 mV (100 mV/s) at 0.1 Hz (Fig. 1 ). Ni 2+ (5 mmol/L) was added to define I Na/Ca through subtracting the post-Ni
2+
trace from the total current trace.
Western blot analysis of NCX1
The myocardial tissues from control and CIHH rats were homogenated in a lysis buffer containing (in mmol/L): Tris HCl 15, NaHCO 3 10, sucrose 250, and ethylenediaminetetraacetic acid 1 (2°C, pH 7.0). The homogenate was centrifuged for 5 minutes at 5,000 g to remove cellular debris. The supernatant was centrifuged at 100,000 g for 60 minutes and then discarded. The pellet containing the sarcolemma-enriched fraction was resuspended in a solution containing (in mmol/L): NaCl 100, LiCl 50, KCl 6, and HEPES-Tris 4) . All solutions contained three protease inhibitors: aprotinin (1 μg/mL), phenylmethylsulfonyl fluoride (0.2 mmol/L), and leupeptin (1 μg/mL). The quantification of the proteins was determined using bicinchoninic acid assay. The protein level of NCX1 in the sarcolemmal membrane was determined using Western blot analysis. Membrane samples (50 μg) were subjected to 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis. Proteins were electrophoretically transferred to polyvinylidene difluoride membranes and probed with monoclonal anti-NCX1 (1:500 dilution; Abcam, Cambridge, UK). The membranes were then incubated with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G (1:5,000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). The immunoreactions were visualized using an ECL detection kit (Pierce Biotechnology, Rockford, IL, USA). The X-ray film was scanned using an image documentation system (Labworks, Costa Mesa, CA, USA), and protein levels were quantified by Image J software (http://rsb.info.nih.gov/ij/).
Data analysis
Data were expressed as means ± standard error of the mean. Differences in parameters before and after ischemia were analyzed using Student's t-test. Comparison among groups were evaluated using a oneway analysis of variance followed by a Dunnett's post hoc test. Statistical significance was accepted when p < 0.05.
Results
Effects of CIHH on ventricular function and infarct size in developing rats
Under basal conditions, the CF was significantly higher in CIHH rats than in CON rats (9.5±0.2 mL in the CIHH group vs. 8.4±0.3 mL in the CON group, p<0.05, Table 1 ). The basal LVDP, +(LVdP/dt) max , -(LVdP/dt) max , and LVEDP were comparable in the CON and CIHH rats. During I/R, the LVDP, +(LVdP/dt) max , and -(LVdP/dt) max were decreased, whereas the LVEDP was increased in all groups of rats. However, the changes in left ventricular function and CF were less attenuated in the CIHH rats than in the CON rats (p<0.05). The degrees of recovery in the LVDP, +(LVdP/dt) max , -(LVdP/dt) max and LVEDP after I/R were greater in the CIHH rats than in the CON rats (p<0.05). Infarct size induced by I/R was significantly lower in the CIHH rats than in the CON rats (p<0.01, Fig. 2) .
We also determined the effects of Bay K8644, an L-type Ca 2+ channel agonist, and ryanodine, a sarcoplasmic reticulum ryanodine receptor agonist, on cardiac function and cardiac infarction size in the CON and CIHH rats. We found that both Bay K8644 (0.5 µmol/L) and ryanodine (10 nmol/L) had no significant effect on basal cardiac function before I/R in all rats. However, a more severe damage of cardiac function and greater infarction size after I/R were observed both in CON+Bay K8644 and in CON+Rya rats than in CON rats. Furthermore, the cardioprotection of CIHH was attenuated by the administration of Bay K8644 or ryanodine (p<0.05, Fig. 2 ). ] i in ventricular myocytes increased after 5 minutes of ischemia followed by 10 minutes of reperfusion in both the CON and CIHH rats (Fig. 3) . This increase in [Ca 2+ ] i was significantly less in the CIHH rats than in the CON rats (28.3±2.1% in the CIHH group vs. 50.6±5.1% in the CON group, p<0.01, Fig. 3 ). These data suggest that CIHH exerts a protective effect against I/R-induced calcium-overload in cardiomyocytes.
Ma et al.: Intermittent Hypoxia and Cardiac Ischemia in Developing Rats
Furthermore, we determined the role of L-type Ca 2+ channel and protein kinase C in CIHH-induced reduction of [Ca 2+ ] i after I/R. We found that Bay K8644 (0.5 µmol/L ) and : maximum rate of decline of left ventricular developed pressure; CF: coronary flow; CON: control group; CIHH: chronic intermittent hypobaric hypoxia group. CIHH+Rya or CON+Rya: Ryanodine (10 nM) was administered at the beginning of reperfusion in the CIHH group or CON group; CIHH+Bay or CON+Bay: The Bay K8644 group (0.5 µM) was administered at the beginning of reperfusion in the CIHH group or CON group. Data are expressed as mean ± standard error of the mean, n=6 rats in each group. ] i did not significantly differ between CON and CON+chelerythrine group of rats after I/R (Fig. 3) . However, Bay K8644 or chelerythrine treatment increased [Ca 2+ ] i in the CIHH group to the levels in the CON rats (Fig. 3) .
Effects of CIHH on NCX currents
The Ni 2+ -sensitive I Na/Ca in ventricular myocytes did not differ significantly between the CON and CIHH rats in normal extracellular solution (p>0.05). After 5-minute perfusion with simulated ischemic solution, Ni 2+ -sensitive I Na/Ca in ventricular myocytes in the CON rats was decreased in both the positive potentials (outward current) and the negative potentials (inward current) compared with that in the CIHH rats (p<0.05, Figs. 4 and 5) . The degree of reduction of the inward current was greater than that of the outward current in myocystes in the CON rat (p<0.05, Figs. 1, 4 , and 5). In addition, we determined the reversal potential of I Na/Ca in ventricular myocytes from the CON and CIHH rats. During simulated ischemia, the change of reversal potential of I Na/Ca in the CON myocytes (from -40.4 ± 5.2 mV to -55.3 ± 4.2 mV) was greater than that in the CIHH myocytes (from -40.3 ± 4.7 mV to -38.4 ± 3.9 mV; p<0.05, Fig. 4) .
Effects of CIHH on NCX1 protein expression in sarcolemmal membrane
To further determine the mechanisms responsible for the protective effect of CIHH on calcium homeostasis of cardiomyocytes during I/R, we examined the effect of CIHH on NCX1 expression in the sarcolemmal membrane. The protein levels of NCX1 were decreased markedly at 30 minutes ischemia (I30), 5 minutes (R5) and 60 minutes reperfusion (R60) during I/R in all cardiomyocytes, but the decrease in NCX1 expression was significantly attenuated in the CIHH rats compared with the CON rats (p< 0.05, Fig. 6 ).
Discussion
This study investigated the role of NCX in the cardiac protection against I/R-induced calcium overload conferred by CIHH treatment in developing rats. We found that CIHH treatment had no effect on basal cardiac function, [Ca 2+ ] i , I Na/Ca , and NCX1 protein level. However, CIHH significantly enhanced the recovery of cardiac function after I/R, decreased The depression of inward I Na/Ca at -80 mV (upper panel) and outward I Na/Ca at +60 mV (bottom panel) under non-ischemia and ischemia from ventricular myocytes in CON and CIHH rats. n=6 cells from 6 rats for each group. * p < 0.05, ** p < 0.01 vs. corresponding non-ischemia. The upper panel represents outward current, and the lower panel represents inward current.Note that the outward current was suppressed by 70%, and 19%, while decrease of the inward current was suppressed by 85%, and 10%. ] i , and reduced the inhibition of I Na/Ca and NCX1 protein expression during I/R. Consistent with our previous study, we confirmed in this study that CIHH exerts a cardiac protective effect in developing rats. We demonstrated for the first time that the cardioprotective effect of CIHH treatment in developing rats might be through maintaining calcium homeostasis in ventricular myocytes via a reduction of Ca 2+ influx mediated by a "reverse mode" of I Na/Ca and the preservation of NCX1 expression during I/R. Also, it is likely that PKC activation contributes to the CIHH cardioprotection in developing rats.
It is well established that Ca 2+ homeostasis is essential for maintaining cardiac function. During I/R, myocardial [Ca 2+ ] i overload [33] may lead to cellular injury and cell death [26] . Reducing [Ca 2+ ] i and maintaining Ca 2+ homeostasis during I/R are strategies to protect myocytes from I/R injury [1, 29] . A study using adult rats showed that CIHH protects the heart through decreasing intracellular calcium and antagonizing calcium overload during I/R [26] . In this study, we found that the increase of [Ca 2+ ] i or calcium overload of myocardium during I/R was suppressed in CIHH-treated rats. These data suggest that the anti-calcium overload effect of CIHH might be one of the mechanisms for cardioprotection of CIHH in the developing rat. It has been shown that the cardioprotective effects of CIHH in the adult rat are related to the maintenance of calcium homeostasis via activation of PKC isoforms [34] . Similarly, we found that the anti-calcium overload effect of CIHH in developing rats was inhibited by the PKC inhibitor, suggesting that the activation of PKC contributes to the Ca overload during I/R in adult rats [26] .
In this study, we found that Bay K8644 treatment had no significant effect on basal cardiac function and [Ca 2+ ] i before ischemia in CON rats, but induced more severe damage in cardiac function and increased intracellular calcium concentration after I/R in CON+Bay group of rats than in CON rats. Furthermore, Bay K8644 treatment decreased cardiac function and elevated [Ca 2+ ] i in CIHH+Bay rats. These data suggest that Bay K8644 could reduce CIHHinduced cardiac protective effect during I/R through opening L-type calcium channel. In addition, we found that ryanodine treatment had no effect on basal cardiac function before I/R in CON rats, but induced more severe damage in cardiac function after I/R in CON+Rya group of rats than in CON rats. These data suggest that the calcium-release induced by ryanodine at this concentration in this experiment did not affect cardiac function before I/R, but aggregate calcium overload induced by I/R and then lead to greater damage of cardiac function. Together with the data showing that CIHH-induced cardioprotection on cardiac function was abolished by ryanodine, we propose that CIHH-induced cardioprotection is related to suppression of intracellular calcium overload through inhibiting L- ] i and maintaining Ca 2+ homeostasis in the heart in an age-dependent manner. It has been shown that NCX is homogenously expressed in early embryonic and fetal hearts, and that its expression level is high in the fetal heart but gradually decreases after birth and during the development process [37] . The high expression of NCX in developing cardiomyocytes is important for the regulation of excitation-contraction coupling in developing animals [38] . At birth, excitation-contraction coupling can occur in the absence of the sarcoplasmic reticulum Ca 2+ release presumably by reverse mode NCX activity [38] . Therefore, it is likely that NCX is essential in the regulation of Ca 2+ homeostasis in developing hearts. It was reported that enhanced gene expression of NCX attenuates ischemic and hypoxic contractile dysfunction [39] . A previous study of the adult heart has shown that, although CIHH has little effect on the myocardial NCX1 protein level, CIHH maintains NCX activity during I/R [26, 34] . In the present study, CIHH-treated developing rats displayed an increase in NCX1 protein levels with decreased [Ca 2+ ] i in myocardium during I/R, suggesting that the increase in the NCX protein expression contributes to the anti-calcium overload effects of CIHH.
The transmembrane current generated by NCX depends on its reversal potential. If the membrane potential depolarizes to become more positive than the reversal potential, then NCX acts in "reverse" mode (Ca 2+ in and Na + out). The membrane potential of cardiomyocytes in the normal resting state is more negative than the reversal potential of I Na/Ca . Therefore, NCX acts in "forward" mode (Na + in and Ca 2+ out) and extrudes Ca 2+ from the cells and generates inward currents in membrane potentials near the resting membrane potential [40] . It was reported that I Na/Ca was suppressed by anoxia [40] . Also, in adult rats, CIHH preserves calcium homeostasis by preventing I/R-induced inhibition of the NCX current [26] . We similarly found in developing rats that inward and outward I Na/Ca (especially inward I Na/Ca ) were decreased by a hyperpolarizing shift of reversal potential during the late phase of ischemia, which delays cytosolic Ca 2+ efflux and leads to Ca 2+ overload. For CIHH-treated developing rats, the decrease of inward and outward I Na/Ca as well as the hyperpolarizing shift of reversal potential during I/R were smaller than those in the control rats, suggesting that CIHH protects cardiomyocytes against Ca 2+ overload through alleviating the inhibition of I Na/Ca , especially inward I Na/Ca .
A previous study has shown that the suppression of I Na/Ca is mediated by ischemiainduced intracellular acidosis [41] . Because CIHH preserves intracellular pH during I/R by PKC activation [42, 43] , it is possible that this mechanism mediates the suppression of I Na/Ca in CIHH-treated rats. Furthermore, it has been shown that an increase in cytosolic ATP stimulates I Na/Ca in cardiac myocytes [44] . The protective effect of CIHH may be related to increased capacity of cardiac anaerobic metabolism, increased energy utilization capacity, and possibly, selection of metabolic pathways or substrates with a higher energy efficiency that would decrease the oxygen requirements [30, 45] . The antagonizing effect of CIHH on the inhibition of I Na/Ca in ventricular myocytes during ischemia may be related to the improvement of energy metabolism induced by CIHH.
In conclusion, this study demonstrates for the first time that CIHH protects the developing rat heart through reducing calcium-overload and preserving I Na/Ca and NCX1 protein expression during I/R. PKC activation might also be involved in the protective process of CIHH.
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